CEO Dunde Yu described demand during the holiday period as “robust” and noted, During this holiday, Tuniu recorded ...

Adjusted EBITDA -- Adjusted EBITDA was $60.7 million in Q2 2025, up from $8.3 million in the same period last year. Net ...

August 14, 2025BioLineRx Ltd. misses on earnings expectations. Reported EPS is $-1 EPS, expectations were $-0.35. Operator: ...

Q2 2025 Earnings Call Transcript August 14, 2025 Operator: Welcome, ladies and gentlemen, and thank you for your patience.

Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...

Q2 2025 Earnings Conference Call August 14, 2025 5:00 PM ETCompany ParticipantsDomenic Della Penna - Executive VP ...

TORM PLC (TRMD) reports a strong quarter with increased earnings guidance, despite facing geopolitical uncertainties and fleet age concerns.

Edible Garden AG Incorporated (NASDAQ: EDBL) Q2 2025 Earnings Call Transcript August 14, 2025 Edible Garden AG Incorporated ...

Q2 2025 Earnings Call Transcript August 14, 2025Brainstorm Cell Therapeutics Inc. beats earnings expectations.

Coherent Corp (COHR) reports robust revenue growth and strategic partnerships, while navigating challenges in industrial markets.

Tuniu Corporation ( NASDAQ: TOUR) Q2 2025 Earnings Conference Call August 15, 2025 8:00 AM ET Anqiang Chen - Corporate Participant Financial Controller - Corporate Participant Dunde Yu - Founder, ...

Total Revenue-- $104,000,000 in total revenue (GAAP) for Q2 2025, reflecting 30.6% year-over-year growth mainly driven by increased revenue from major business operations. Subscription Revenue-- ...